bariatric embolization
Recently Published Documents


TOTAL DOCUMENTS

46
(FIVE YEARS 19)

H-INDEX

7
(FIVE YEARS 2)

2022 ◽  
Vol 33 (1) ◽  
pp. 28-32
Author(s):  
Jenanan Vairavamurthy ◽  
Frank Yuan ◽  
Robert A. Anders ◽  
Dara L. Kraitchman ◽  
Clifford R. Weiss

2021 ◽  
pp. 893-904
Author(s):  
Clifford R. Weiss ◽  
Godwin Abiola

2021 ◽  
Vol 16 (11) ◽  
pp. 3574-3576
Author(s):  
Mubin Syed ◽  
Wajahat Efridi ◽  
Tanya Khan ◽  
Feras Deek ◽  
Matthew Kurian ◽  
...  

2021 ◽  
pp. 233-241
Author(s):  
Mario A. Cedillo ◽  
Kirema Garcia-Reyes ◽  
Aaron M. Fischman

2020 ◽  
Vol 2 ◽  
pp. 101-112
Author(s):  
Jenanan P. Vairavamurthy ◽  
Omid Shafaat ◽  
Clifford R. Weiss

2020 ◽  
Vol 04 (02) ◽  
pp. 195-205
Author(s):  
Varun R. Danda ◽  
Christopher R. Bailey ◽  
Clifford R. Weiss

AbstractThe obesity epidemic is a growing public health concern that has a severe effect on the health care system with significant morbidity, mortality, and cost. Treatment options for obesity include lifestyle modifications, pharmacotherapy, and bariatric surgery. Newer, less-invasive therapies including endoscopic bariatric procedures have been developed in recent years to fill the treatment gap that exists between noninvasive approaches and surgery. Bariatric artery embolization (BAE) is a novel minimally invasive endovascular procedure that has been developed to treat obesity. Recent evidence has suggested that bariatric embolization is well tolerated and can induce clinically significant weight loss through a hormonally mediated mechanism. This article will review existing preclinical and clinical data, and explore future directions of the endovascular treatment of obesity.


Cureus ◽  
2020 ◽  
Author(s):  
Israa Aldawudi ◽  
Prakash C Katwal ◽  
Srood Jirjees ◽  
Zin Mar Htun ◽  
Safeera Khan

2020 ◽  
Vol 23 (1) ◽  
pp. 100658 ◽  
Author(s):  
Nima Hafezi-Nejad ◽  
Christopher R. Bailey ◽  
Clifford R. Weiss

Sign in / Sign up

Export Citation Format

Share Document